Dolman, G. E., Selby, P., & Gelson, W. T. (2018). Ombitasvir/paritaprevir/ritonavir plus dasabuvir regimen may be used safely in combination with sirolimus for the treatment of chronic hepatitis C. BMJ Case Rep.
Stile di citazione ChicagoDolman, Grace Elizabeth, Paul Selby, e William T. Gelson. "Ombitasvir/paritaprevir/ritonavir Plus Dasabuvir Regimen May Be Used Safely in Combination With Sirolimus for the Treatment of Chronic Hepatitis C." BMJ Case Rep 2018.
Citazione MLADolman, Grace Elizabeth, Paul Selby, e William T. Gelson. "Ombitasvir/paritaprevir/ritonavir Plus Dasabuvir Regimen May Be Used Safely in Combination With Sirolimus for the Treatment of Chronic Hepatitis C." BMJ Case Rep 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.